We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities


Premium JewelStreet Manufacturing and Retail EIS
Jewelstreet is on a mission to connect jewellery designers to buyers from all over world. They have 570 designers and brands with over 20,000 unique pieces of jewellery. The funding will be used for marketing to further the profile of Jewelstreet and increase their customer base.
investment: £245,470 target: £300,000 pre-money valuation: £5,545,547
No rating information available
More Information
82%
status: Active 4 days
to go
ADC Biotechnology Limited Technology EIS
ADC Biotechnology provides specialist drug manufacturing services based on its own patented Lock-Release™ processing technology, focused on a new wave of oncology therapeutics called antibody-drug conjugates (“ADCs”) being developed by pharmaceutical companies worldwide.
investment: £6,243,502 target: £6,000,000
No rating information available
More Information
104%
status: Extended
Cotswolds Distillery Catering, Food and Drink EIS
Cotswold Distillery creates quality craft sprits.  Their distillery is vote the top attraction according to trip advisor; they have 3 tours a day, 7 days a week and approximately 30,000 visitors every year.  They have created a single malt whiskey and premium gins both have won awards internationally.  They are looking for funding to build brand awareness and long term growth.
investment: £2,307,940 target: £2,000,000 pre-money valuation: £30,106,520
No rating information available
More Information
115%
status: Extended 5 days
to go
Cipher Surgical Technology EIS
Cipher Surgical have developed a device called The OpClear which can be used in Laparoscopy operations.  The device solves the problem of lenses used in keyhole surgery becoming covered contamination for example blood, tissue and condensation.  The OpClear device uses CO2 and Saline to clean the lense of the device thus saving operating time.
investment: £2,238,455 target: £2,099,988 pre-money valuation: £14,959,216
No rating information available
More Information
107%
status: Extended 3 days
to go
MGB Medical EIS
MGB Biopharma is tackling the worldwide threat of antimicrobial resistance.   The company is in the process of clinical study and designing a new class of antibiotic.  They are looking for investment to start phase 2 of the study with 70% being supported by a grant.
investment: £1,309,621 target: £1,300,000 pre-money valuation: £8,920,126
No rating information available
More Information
101%
status: Stretch 19 days
to go
East London Liquor Company Catering, Food and Drink EIS
East London Liquor Company export from east London to 20 countries worldwide. They have plans to launch in Ibiza, Toronto, Los angles, New York and Shanghai.  They also own their own restaurant. Since 2014 they have grown there team from 4 to 30 people. London dry gin has won many award and the East London Liquor Company produces over 12,000 bottles of gin a month.
investment: £1,292,630 target: £750,000 pre-money valuation: £15,000,000
No rating information available
More Information
172%
status: Extended 5 days
to go
Redag Crop Protection Limited Catering, Food and Drink EIS
Redag Crop is an agrochemical discovery business focused on products that play a vital role in controlling the pests and diseases that threaten our global food supply. The growing population, expected to grow by 8 billion by 2020 and then 9 billion by 2050, will need more crops than the existing land can produce. Each hectare will need to produce 2.5 times as many crops as they do now. 
investment: £1,250,000 target: £1,250,000
No rating information available
More Information
100%
status: Extended
Naked Energy has developed Virtu which is an evolution of standard solar technology.  Traditionally there are two types of technology; one takes the suns energy and converts it to electricity and the other to heat water.  Virtu takes both methods and fuses them together to create an efficient heat exchanger with vacuum tube technology.  They are now looking to grow internationally.
investment: £1,200,858 target: £999,991 pre-money valuation: £7,703,151
No rating information available
More Information
120%
status: Stretch 24 days
to go
Arca is helping to build the market for property market risk transfer by dealing in derivatives for domestic and commercial properties. Nick Ruddell has held senior roles for the last 30 years with banks and big interdealer brokers.
investment: £675,498 target: £1,500,000 pre-money valuation: £6,000,000
No rating information available
More Information
45%
status: Active 9 days
to go
Obby have created a platform that helps independent teachers generate an income doing by giving them access people about crafts using curated, high quality, courses.
investment: £659,578 target: £749,980 pre-money valuation: £3,999,735
No rating information available
More Information
88%
status: Active 11 days
to go
Cell Guidance Systems Medical EIS
Cell Guidance Systems is developing a technology called PODS (Polyhedrin Delivery System) PODS allow them to deliver therapeutic proteins accurately and over long periods of time. PODS enable proteins to treat diseases, such as Parkinson’s disease and osteoarthritis.
investment: £619,180 target: £500,000 pre-money valuation: £9,250,000
No rating information available
More Information
124%
status: Extended 7 days
to go
SCRUBD specialise in grooming products specifically for men, leaving their skin feeling primed and looking great. SCRUBD use pioneering techniques and methods to create their 100% Natural products with no synthetic chemicals. Their skincare products are made in England and already have 72m Press Reach with more than 60+ pcs coverage.
investment: £570,063 target: £900,000 pre-money valuation: £2,699,296
No rating information available
More Information
63%
status: Active 49 days
to go
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph